These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8266069)

  • 61. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
    Shiver JW; Fu TM; Chen L; Casimiro DR; Davies ME; Evans RK; Zhang ZQ; Simon AJ; Trigona WL; Dubey SA; Huang L; Harris VA; Long RS; Liang X; Handt L; Schleif WA; Zhu L; Freed DC; Persaud NV; Guan L; Punt KS; Tang A; Chen M; Wilson KA; Collins KB; Heidecker GJ; Fernandez VR; Perry HC; Joyce JG; Grimm KM; Cook JC; Keller PM; Kresock DS; Mach H; Troutman RD; Isopi LA; Williams DM; Xu Z; Bohannon KE; Volkin DB; Montefiori DC; Miura A; Krivulka GR; Lifton MA; Kuroda MJ; Schmitz JE; Letvin NL; Caulfield MJ; Bett AJ; Youil R; Kaslow DC; Emini EA
    Nature; 2002 Jan; 415(6869):331-5. PubMed ID: 11797011
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Protection against AIDS? The example of African monkeys].
    Jacquelin B; Rescanière O; Liovat AS; Petitjean G; Barré-Sinoussi F; Müller-Trutwin M
    Med Sci (Paris); 2010 May; 26(5):461-3. PubMed ID: 20510140
    [No Abstract]   [Full Text] [Related]  

  • 63. Monkey business over AIDS vaccine.
    Weiss R
    BMJ; 1991 Oct; 303(6807):872. PubMed ID: 1933002
    [No Abstract]   [Full Text] [Related]  

  • 64. Novel campaign to test live HIV vaccine.
    Cohen J
    Science; 1997 Aug; 277(5329):1035. PubMed ID: 9289848
    [No Abstract]   [Full Text] [Related]  

  • 65. Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines.
    Amara RR; Villinger F; Staprans SI; Altman JD; Montefiori DC; Kozyr NL; Xu Y; Wyatt LS; Earl PL; Herndon JG; McClure HM; Moss B; Robinson HL
    J Virol; 2002 Aug; 76(15):7625-31. PubMed ID: 12097576
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Breakthrough Virus Neutralization Resistance as a Correlate of Protection in a Nonhuman Primate Heterologous Simian Immunodeficiency Virus Vaccine Challenge Study.
    Lee FH; Mason R; Welles H; Learn GH; Keele BF; Roederer M; Bar KJ
    J Virol; 2015 Dec; 89(24):12388-400. PubMed ID: 26423953
    [TBL] [Abstract][Full Text] [Related]  

  • 67. 25 years of HIV research! ... and what about a vaccine?
    Appay V
    Eur J Immunol; 2009 Aug; 39(8):1999-2003. PubMed ID: 19672891
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Animal models for AIDS.
    Letvin NL
    Immunol Today; 1990 Sep; 11(9):322-6. PubMed ID: 2206278
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Simian immunodeficiency virus: possible effects of deworming and tuberculin extrapolated to HIV/AIDS.
    Fincham JE; Adams VJ; Markus MB
    Vaccine; 2003 Jun; 21(19-20):2258-9. PubMed ID: 12744853
    [No Abstract]   [Full Text] [Related]  

  • 70. A strategy for prophylactic vaccination against HIV.
    Salk J; Bretscher PA; Salk PL; Clerici M; Shearer GM
    Science; 1993 May; 260(5112):1270-2. PubMed ID: 8098553
    [No Abstract]   [Full Text] [Related]  

  • 71. Animal models for HIV/AIDS research.
    Hatziioannou T; Evans DT
    Nat Rev Microbiol; 2012 Dec; 10(12):852-67. PubMed ID: 23154262
    [TBL] [Abstract][Full Text] [Related]  

  • 72. AIDS vaccines. At conference, hope for success is further attenuated.
    Cohen J
    Science; 1994 Nov; 266(5188):1154. PubMed ID: 7973692
    [No Abstract]   [Full Text] [Related]  

  • 73. Monkey-human viral hybrid is new weapon in AIDS fight.
    Cohen J
    Science; 1992 Jul; 257(5069):478. PubMed ID: 1636081
    [No Abstract]   [Full Text] [Related]  

  • 74. Curtailing the AIDS pandemic.
    Mullins JI
    Science; 1997 Jun; 276(5321):1955-7. PubMed ID: 9221490
    [No Abstract]   [Full Text] [Related]  

  • 75. Abstracts of AIDS Vaccine 2009. Paris, France. October 19-22, 2009.
    Freel SA; Chattopadhyay PK; Lamoreaux L; Zarkowsky D; Overman RG; Ochsenbauer-Jambor C; Kappes JC; Cunningham CK; Denny TN; Weinhold KJ; Ferrari G; Koup RA; Graham BS; Haynes BF; Roederer M; Tomaras GD
    Retrovirology; 2009 Oct; 6 Suppl 3(Suppl 3):O1-52, P1-425. PubMed ID: 19849813
    [No Abstract]   [Full Text] [Related]  

  • 76. What are the correlates of protection?
    Cohen J
    Science; 1993 May; 260(5112):1259. PubMed ID: 8493565
    [No Abstract]   [Full Text] [Related]  

  • 77. In HIV vaccine efforts, new strategies and patience are needed in equal measure.
    Stephenson J
    JAMA; 2002 Dec; 288(21):2671-2. PubMed ID: 12460070
    [No Abstract]   [Full Text] [Related]  

  • 78. AIDS vaccine: new ideas from old approaches.
    Beale AJ
    J R Soc Med; 2003 Jul; 96(7):347-8. PubMed ID: 12835449
    [No Abstract]   [Full Text] [Related]  

  • 79. Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine development.
    Keating SM; Jacobs ES; Norris PJ
    Cytokine Growth Factor Rev; 2012; 23(4-5):193-206. PubMed ID: 22743035
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Baboons as an animal model for human immunodeficiency virus pathogenesis and vaccine development.
    Locher CP; Witt SA; Herndier BG; Tenner-Racz K; Racz P; Levy JA
    Immunol Rev; 2001 Oct; 183():127-40. PubMed ID: 11782253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.